Who owns the CANTEX trademark?

The CANTEX trademark is owned by Cantex Pharmaceuticals, Inc..

What class is the CANTEX trademark registered in?

The CANTEX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for CANTEX?

The USPTO serial number for CANTEX is 98043024.

What is the registration number for CANTEX?

CANTEX is registered under USPTO registration number 0.

Sealvo

Home Search: CANTEXCANTEX #98043024

Back

Updated Sep 29, 2026·26 searches this week

View on USPTO TSDR Find similar marks

CAN

USPTO Trademark Record

PENDING

CANTEX

SN 98043024·Reg 0·Filed Jun 14, 2023

Owner Cantex Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

CANTEX (Serial No. 98043024), Registration No. 0, is a pending US trademark filed on Jun 14, 2023 by Cantex Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Office Action response: October 18, 202619 days remaining

Conflict Analysis

Full conflict analysis for CANTEX (SN 98043024) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CANTEX (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 14, 2023

SERIAL

98043024

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateJun 14, 2023

Serial Number98043024

Registration No.0

Registration DateDec 31, 1969

Status DateApr 18, 2026

Published for OppositionMar 04, 2025

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 28, 2023

First use in commerce: Apr 28, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

44 events

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jul 17, 2026

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jul 17, 2026

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SU - NON-FINAL ACTION - WRITTEN

Apr 18, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Apr 18, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 18, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 11, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 06, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 18, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Oct 17, 2025

SOU EXTENSION 1 GRANTED

SOU EXTENSION 1 FILED

Oct 17, 2025

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Oct 17, 2025

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Oct 17, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 17, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 29, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 04, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Mar 04, 2025

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 26, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 07, 2025

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 06, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Jan 16, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 16, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 16, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Dec 17, 2024

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Oct 28, 2024

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Oct 28, 2024

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 28, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 28, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 28, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Oct 23, 2024

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

WITHDRAWAL OF ATTORNEY GRANTED

Oct 23, 2024

WITHDRAWAL OF ATTORNEY GRANTED

SUSPENSION LETTER WRITTEN

Oct 17, 2024

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Oct 17, 2024

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Oct 17, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 12, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 12, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 12, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 29, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 29, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Mar 12, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 12, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 12, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 04, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 18, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 17, 2023

NEW APPLICATION ENTERED

Other Marks by Cantex Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

DIC

DICOPP

87479296

Cantex Pharmaceuticals, Inc.

ABANDONED

ODS

ODSH

88192072

Cantex Pharmaceuticals, Inc.

ABANDONED

DIC

DICOP

87479273

Cantex Pharmaceuticals, Inc.

ABANDONED

CAN

CANTEX PHARMACEUTICALS

86116194

Cantex Pharmaceuticals, Inc.

ABANDONED

Other Marks by Michael J. Belliveau

Additional USPTO filings handled by the same attorney of record.

LEN

LENMELDY

98028058

REGISTERED

MIN

MINERVA NEUROSCIENCES

86415382

REGISTERED

MOR

MORPHIC

98158293

REGISTERED

97839969

REGISTERED

CANTEX

Run a conflict check

Other Marks by Cantex Pharmaceuticals, Inc.

Other Marks by Michael J. Belliveau

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company